Ayoxxa: Bridging the gap
Cologne-based biotech Ayoxxa Biosystems GmbH announces that Rodney Turner has assumed duties as the interim CEO. Prior CEO Andreas Schmidt has stepped down.
Turner has been an independent member of the Ayoxxa supervisory board since 2014. Prior to that, he was a senior corporate development executive with Life Technologies for almost 10 years.
adobe stock photos - MikeCS Images 
T3 Pharmaceuticals
Adobe stock photos - https://european-biotechnology.com/latest-news/roche-moves-obesity-asset-ct-388-into-phase-iii/